BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34883030)

  • 1. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
    Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
    Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications.
    Karanam NK; Story MD
    Int J Radiat Biol; 2021; 97(8):1044-1054. PubMed ID: 33086019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor treating fields: narrative review of a promising treatment modality for cancer.
    Kutuk T; Atak E; La Rosa A; Kotecha R; Mehta MP; Chuong MD
    Chin Clin Oncol; 2023 Dec; 12(6):64. PubMed ID: 37953242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.
    Li X; Liu K; Xing L; Rubinsky B
    Radiol Oncol; 2023 Sep; 57(3):279-291. PubMed ID: 37665740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of tumor treating fields for malignant brain tumors.
    Zhou Y; Xing X; Zhou J; Jiang H; Cen P; Jin C; Zhong Y; Zhou R; Wang J; Tian M; Zhang H
    Cancer Rep (Hoboken); 2023 May; 6(5):e1813. PubMed ID: 36987739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields.
    Diamant G; Simchony Goldman H; Gasri Plotnitsky L; Roitman M; Shiloach T; Globerson-Levin A; Eshhar Z; Haim O; Pencovich N; Grossman R; Ram Z; Volovitz I
    J Immunol; 2021 Jul; 207(2):709-719. PubMed ID: 34215656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theory and application of TTFields in newly diagnosed glioblastoma.
    Yu A; Zeng J; Yu J; Cao S; Li A
    CNS Neurosci Ther; 2024 Mar; 30(3):e14563. PubMed ID: 38481068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
    Wang Y; Pandey M; Ballo MT
    Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
    Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates.
    Arvind R; Chandana SR; Borad MJ; Pennington D; Mody K; Babiker H
    Crit Rev Oncol Hematol; 2021 Dec; 168():103535. PubMed ID: 34808377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Treating Fields in Glioblastomas: Past, Present, and Future.
    Guo X; Yang X; Wu J; Yang H; Li Y; Li J; Liu Q; Wu C; Xing H; Liu P; Wang Y; Hu C; Ma W
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
    Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines.
    Karanam NK; Srinivasan K; Ding L; Sishc B; Saha D; Story MD
    Cell Death Dis; 2017 Mar; 8(3):e2711. PubMed ID: 28358361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
    Saria MG; Kesari S
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
    Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
    Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.
    Swanson KD; Lok E; Wong ET
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):8. PubMed ID: 26739692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
    Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
    Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
    Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
    Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
    Shams S; Patel CB
    J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
    Ghiaseddin AP; Shin D; Melnick K; Tran DD
    Curr Treat Options Oncol; 2020 Jul; 21(9):76. PubMed ID: 32734509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.